Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.
Khera, Rohan
Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study. [electronic resource] - BMJ (Clinical research ed.) Jul 2018 - k2357 p. digital
Publication Type: Journal Article
1756-1833
10.1136/bmj.k2357 doi
Aged
American Heart Association
Antihypertensive Agents--therapeutic use
China--epidemiology
Cross-Sectional Studies
Eligibility Determination
Female
Health Policy
Humans
Hypertension--drug therapy
Longitudinal Studies
Male
Middle Aged
Practice Guidelines as Topic
Prevalence
United States--epidemiology
Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study. [electronic resource] - BMJ (Clinical research ed.) Jul 2018 - k2357 p. digital
Publication Type: Journal Article
1756-1833
10.1136/bmj.k2357 doi
Aged
American Heart Association
Antihypertensive Agents--therapeutic use
China--epidemiology
Cross-Sectional Studies
Eligibility Determination
Female
Health Policy
Humans
Hypertension--drug therapy
Longitudinal Studies
Male
Middle Aged
Practice Guidelines as Topic
Prevalence
United States--epidemiology